{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:13:22Z","timestamp":1783671202063,"version":"3.55.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1038\/s41591-023-02515-0","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T06:01:55Z","timestamp":1694152915000},"page":"2185-2186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decoding antigen escape and multiple myeloma relapse after targeted immunotherapy"],"prefix":"10.1038","volume":"29","member":"297","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"2515_CR1","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3324\/haematol.2020.266841","volume":"108","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. BCMA loss in the epoch of novel immunotherapy for multiple myeloma: from biology to clinical practice. Haematologica 108, 958\u2013968 (2023). This review article summarizes the existing data on BCMA loss after immunotherapy in MM.","journal-title":"Haematologica"},{"key":"2515_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood-2020-137650","volume":"136","author":"N Leblay","year":"2020","unstructured":"Leblay, N. et al. Cite-Seq profiling of T cells in multiple myeloma patients undergoing BCMA targeting CAR T or BiTES immunotherapy. Blood 136, 11\u201312 (2020). This conference abstract describes the emergence of TNFRSF17 biallelic deletion from pre-existing subclones with monoallelic TNFRSF17 deletion during progression after anti-BCMA CAR T cell therapy.","journal-title":"Blood"},{"key":"2515_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41591-021-01245-5","volume":"27","author":"MC Da Vi\u00e0","year":"2021","unstructured":"Da Vi\u00e0, M. C. et al. Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma. Nat. Med. 27, 616\u2013619 (2021). This study describes the selection of clones with homozygous TNFRSF17 deletion as an escape mechanism after anti-BCMA CAR T cell therapy and reports heterozygous TNFRSF17 loss or monosomy 16 as a potential risk factor for BCMA loss after targeted immunotherapy.","journal-title":"Nat. Med."},{"key":"2515_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21177-5","volume":"12","author":"MK Samur","year":"2021","unstructured":"Samur, M. K. et al. Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma. Nat. Commun. 12, 868 (2021). This research article associates BCMA antigen loss through TNFRSF17 monoallelic deletion and a truncating mutation after anti-BCMA CAR T cell therapy with lack of response to subsequent infusion of CAR T cells.","journal-title":"Nat. Commun."},{"key":"2515_CR5","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1182\/bloodadvances.2021004418","volume":"5","author":"MS Truger","year":"2021","unstructured":"Truger, M. S. et al. Single- and double-hit events in genes encoding immune targets before and after T cell-engaging antibody therapy in MM. Blood Adv. 5, 3794\u20133798 (2021). This research article reports that homozygous TNFRSF17 loss after anti-BCMA TCE therapy precluded a response to subsequent anti-BCMA therapies.","journal-title":"Blood Adv."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02515-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02515-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02515-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:17:49Z","timestamp":1783667869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02515-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2515"],"URL":"https:\/\/doi.org\/10.1038\/s41591-023-02515-0","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"8 September 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}